Literature DB >> 15310694

Trends in coronary artery revascularisation procedures in Western Australia, 1980-2001.

M S T Hobbs1, K A McCaul, M W Knuiman, J M Rankin, I Gilfillan.   

Abstract

OBJECTIVES: To describe trends in the use of coronary artery revascularisation procedures (CARPs) and to determine whether or when CARP rates will stabilise.
SETTING: State of Western Australia. PATIENTS: All patients treated by coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) between 1980 and 2001.
DESIGN: Descriptive study. MAIN OUTCOME MEASURES: Age standardised rates of first and total CARPs, CABGs, and PCIs.
RESULTS: Overall rates for both total and first CARPs among men and women rose steeply from 1980 to 1993, when they abruptly stabilised or actually started to decline. Rates in age groups under 65 years tended to rise earlier in the period and remained relatively flat, while rates for people over the age of 75 years started to rise later and were still increasing at the end of the study.
CONCLUSIONS: Despite continuing increases in capacity to perform both CABG and PCI in Western Australia and evidence of continuing increases in the use of CARPs in the elderly population, rates appear to have stabilised for the first time since they were introduced.

Entities:  

Mesh:

Year:  2004        PMID: 15310694      PMCID: PMC1768454          DOI: 10.1136/hrt.2003.022160

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  28 in total

1.  Improved clinical outcome after widespread use of coronary-artery stenting in Canada.

Authors:  J M Rankin; J J Spinelli; R G Carere; D R Ricci; I M Penn; J D Hilton; M A Henderson; R I Hayden; C E Buller
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

2.  Mobile Australians: a moving target for epidemiologists.

Authors:  P J Bradshaw; K Jamrozik; P Jelfs; M Le
Journal:  Med J Aust       Date:  2000-06-05       Impact factor: 7.738

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.

Authors:  F Zijlstra; J C Hoorntje; M J de Boer; S Reiffers; K Miedema; J P Ottervanger; A W van 't Hof; H Suryapranata
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

5.  Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events.

Authors:  F D Loop; B W Lytle; D M Cosgrove; R W Stewart; M Goormastic; G W Williams; L A Golding; C C Gill; P C Taylor; W C Sheldon
Journal:  N Engl J Med       Date:  1986-01-02       Impact factor: 91.245

6.  Coronary artery bypass surgery and coronary angiography in the United States, 1979-1983.

Authors:  R F Gillum
Journal:  Am Heart J       Date:  1987-05       Impact factor: 4.749

7.  Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

Authors:  H Tunstall-Pedoe; K Kuulasmaa; M Mähönen; H Tolonen; E Ruokokoski; P Amouyel
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

8.  Trends in two year risk of repeat revascularisation or death from cardiovascular disease after coronary artery bypass grafting or percutaneous coronary intervention in Western Australia, 1980-2001.

Authors:  K A McCaul; M S T Hobbs; M W Knuiman; J M Rankin; I Gilfillan
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

9.  Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease.

Authors:  W S Weintraub; E L Jones; S B King; J Craver; J S Douglas; R Guyton; H Liberman; D Morris
Journal:  Am J Cardiol       Date:  1990-01-15       Impact factor: 2.778

10.  Coronary heart disease and related procedures. National Hospital Discharge Survey data.

Authors:  M Feinleib; R J Havlik; R F Gillum; R Pokras; E McCarthy; M Moien
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

View more
  5 in total

1.  Trends in two year risk of repeat revascularisation or death from cardiovascular disease after coronary artery bypass grafting or percutaneous coronary intervention in Western Australia, 1980-2001.

Authors:  K A McCaul; M S T Hobbs; M W Knuiman; J M Rankin; I Gilfillan
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

2.  Impact of the introduction of drug eluting stents on clinical outcomes in patients undergoing percutaneous and surgical coronary artery revascularisation procedures in Western Australia.

Authors:  Frank M Sanfilippo; Jamie M Rankin; Michael S T Hobbs; Michael Nguyen; Matthew W Knuiman; Patricia Berg; Eric G Whitford; Randall Hendriks; Bernard E Hockings; Michael Muhlmann; Mark Newman; Robert Larbalestier; Ian Gilfillan; Thomas G Briffa
Journal:  BMC Cardiovasc Disord       Date:  2013-07-05       Impact factor: 2.298

3.  Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005.

Authors:  Tom Briffa; S Hickling; M Knuiman; M Hobbs; J Hung; F M Sanfilippo; K Jamrozik; P L Thompson
Journal:  BMJ       Date:  2009-01-26

4.  Trends in percutaneous coronary interventions in new South Wales, Australia.

Authors:  Daminda P Weerasinghe; Farhat Yusuf; Nicholas J Parr
Journal:  Int J Environ Res Public Health       Date:  2009-01-12       Impact factor: 4.614

5.  Adapting a Markov Monte Carlo simulation model for forecasting the number of coronary artery revascularisation procedures in an era of rapidly changing technology and policy.

Authors:  Haider R Mannan; Matthew Knuiman; Michael Hobbs
Journal:  BMC Med Inform Decis Mak       Date:  2008-06-25       Impact factor: 2.796

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.